Report Overview

Increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and blood disorders, growing demand for leukapheresis in research and clinical applications, and favorable government initiatives and investments in healthcare infrastructure are projected to propel the expansion of Saudi Arabia leukapheresis market during the forecast period between 2023 and 2029.

Saudi Arabia Leukapheresis Market - Industry Trends & Forecast Report, 2029

Saudi Arabia leukapheresis market size was estimated at USD 968.79 million in 2022. During the forecast period between 2023 and 2029, the size of Saudi Arabia leukapheresis market size is projected to grow at CAGR of 7.51% reaching a value of USD 1,604.04 million by 2029. Major growth drivers for Saudi Arabia leukapheresis market include increasing number of blood cancer cases, growing awareness about leukapheresis procedures, and the availability of advanced medical infrastructure in the country. Leukapheresis is a medical procedure that involves the separation and removal of white blood cells from the blood of a patient. In Saudi Arabia, the leukapheresis market is gaining traction due to the growing prevalence of blood disorders, including leukemia and lymphoma. Leukapheresis is primarily used for the treatment of these disorders by removing excess white blood cells and reducing the number of cancerous cells in the blood. Moreover, the presence of major market players and government initiatives to improve healthcare facilities are expected to further boost the growth of the leukapheresis market in Saudi Arabia. The demand for leukapheresis procedures is also expected to increase due to the rising incidence of autoimmune diseases and the growing demand for personalized medicine.

Saudi Arabia Leukapheresis Market – Overview

Leukapheresis is a laboratory procedure that involves separating white blood cells from a blood sample, and returning the remaining blood cells to the bloodstream. Its growth is likely to be fueled by the rising prevalence of leukemia, which is a type of cancer that affects the early forms of blood cells, typically the white blood cells or leucocytes responsible for fighting against infections caused by foreign particles. Leukapheresis is commonly used to treat chronic lymphocytic leukemia (CLL) and patients with extremely high white blood cell counts. The demand for leukapheresis is anticipated to witness substantial growth due to increasing research and development activities in the product portfolio.

Saudi Arabia Leukapheresis Market

Growth Drivers

Growing Demand for Leukapheresis in Research and Clinical Applications

Saudi Arabia leukapheresis market is expected to grow due to the increasing demand for leukapheresis in both research and clinical applications. As leukapheresis is a procedure that is commonly used in the treatment of various blood disorders, autoimmune disorders, and cancers, the growing demand for these treatments is likely to drive the expansion of the market. Additionally, the rising use of leukapheresis in research applications, such as in the development of cell therapies, is expected to further boost the demand for the procedure and drive the growth of the Saudi Arabia leukapheresis market.

Restraints

High Expense of Leukapheresis Product

The rising mortality rate from leukemia is attributed to the high cost of care, which limits the access of patients to adequate treatment. This has resulted in a slow growth rate for the global leukapheresis market. Leukemia treatment requires the use of leukapheresis products, but the high cost of these items means that they are not affordable for most people, hindering the market's growth potential. Moreover, the development of the leukapheresis treatment method and its components, such as leukopaks, is still in its early stages. Leukemia, which is a form of blood cancer, is a severe disease with a high mortality rate. The World Health Organization predicts that blood cancer could cause around 10 million deaths by 2020, highlighting the urgent need for affordable and accessible treatment options for leukemia patients.

Impact of COVID -19 on Saudi Arabia Leukapheresis Market

COVID-19 pandemic had a detrimental impact on the global economy, leading to disruptions in business operations and supply chains. Lockdown measures imposed by various countries to control the spread of the virus have had a profound effect on industries, trade, and related services. The treatment of leukapheresis requires a substantial amount of blood transmission, which has led to people avoiding treatment due to fears of contracting COVID-19. Additionally, the pandemic has posed an existential threat to millions of businesses, especially those in the informal economy who lack social security, access to quality healthcare, and productive assets.

Saudi Arabia Leukapheresis Market

Segmental Coverage

Saudi Arabia Leukapheresis Market – By Product Type

By product type, Saudi Arabia leukapheresis market is bifurcated into Leukapheresis Devices and Leukapheresis Disposables segments. The leukapheresis disposables segment holds a higher share in the Saudi Arabia leukapheresis market, for as there is a growing demand for leukapheresis procedures in Saudi Arabia due to an increasing number of patients suffering from blood-related disorders such as leukemia and lymphoma. This has led to a corresponding increase in demand for leukapheresis disposables. Also, in healthcare settings, there is a growing awareness of the importance of infection control in Saudi Arabia. The use of single-use leukapheresis disposables can help to reduce the transmission of infections between patients, which is particularly important in cases of blood-related disorders.

Saudi Arabia Leukapheresis Market – By Application

Based on application, Saudi Arabia leukapheresis market is split into Research Applications and Therapeutic Applications segments. The research application segment holds a higher segment in the Saudi Arabian leukapheresis market. The country has been heavily investing in research and development activities, particularly in the medical sciences, leading to a corresponding rise in demand for leukapheresis procedures for research purposes. Advancements in technology have also made the use of leukapheresis for research more sophisticated, allowing for the collection of more precise and accurate data, further driving demand for these procedures. Additionally, collaborations with leading international research institutions have facilitated the exchange of knowledge and expertise, increasing demand for leukapheresis procedures for research purposes in the country.

Saudi Arabia Leukapheresis Market – By End User

Based on end user, Saudi Arabia leukapheresis market is segmented into Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Transfusion Centers. The Blood Component Providers & Blood Centers segment dominate the Saudi Arabian leukapheresis market. The increasing demand for blood components in Saudi Arabia, mainly due to the rise in blood-related disorders, has led to a growing demand for leukapheresis procedures that these providers offer. Likewise, these providers have access to advanced medical technology and equipment, which allows for more efficient and accurate leukapheresis procedures, enabling them to meet the growing demand for blood components and maintain their market dominance. Also, the Saudi Arabian government has been investing heavily in healthcare infrastructure, which includes supporting blood component providers and blood centers, thus facilitating their growth and dominance in the leukapheresis market.

Competitive Landscape

Major players operating in Saudi Arabia leukapheresis market include Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation, Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, and BioIVT. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Scope of the Report

By Product Type

• Leukapheresis Devices

• Leukapheresis Disposables

By Application

• Research Applications

• Therapeutic Applications

By End Users

• Blood Component Providers & Blood Centers

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Hospitals & Transfusion Centers